[1]
Toren, P. et al. 2014. Active surveillance in patients with a PSA >10 ng/mL. Canadian Urological Association Journal. 8, 9-10 (Oct. 2014), e702–7. DOI:https://doi.org/10.5489/cuaj.2121.